Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Immunology
  4. Progressive Demyelination in the Presence of Serum Myelin Oligodendrocyte Glycoprotein-IgG: A Case Report

Progressive Demyelination in the Presence of Serum Myelin Oligodendrocyte Glycoprotein-IgG: A Case Report

Frontiers in Neurology, 2018 · DOI: 10.3389/fneur.2018.00340 · Published: May 15, 2018

ImmunologyNeurology

Simple Explanation

This case report describes a patient with progressive demyelinating opticospinal disease, IgG-oligoclonal bands (OCB), and serum MOG-IgG. The patient initially presented with loss of visual acuity and later experienced bilateral optic neuritis, eventually leading to a diagnosis of progressive MS. Despite various treatments, the patient's condition continued to deteriorate, and retrospective analysis revealed the presence of MOG-IgG antibodies in the serum.

Study Duration
Not specified
Participants
1 white man of western European ancestry
Evidence Level
Case Report

Key Findings

  • 1
    The patient was MOG-IgG-positive and experienced progressive neurological deterioration after two episodes of ON.
  • 2
    MRI scans revealed new lesions in the brain, cerebellum, brainstem, and spinal cord, indicating progressive demyelination.
  • 3
    The case highlights the atypical presentation of MOG-IgG-related entities, which are typically considered part of NMOSD but can sometimes resemble MS.

Research Summary

The clinical diagnosis of patients with autoantibodies directed to conformational myelin oligodendrocyte glycoprotein MOG-IgG, can be challenging because of atypical clinical presentation (1–3). To contribute to the characterization of MOG-related demyelination, we describe the case of a patient with progressive demyelinating opticospinal disease, IgG-oligoclonal bands (OCB), and serum MOG-IgG. MOG-IgG-related entities are considered part of the NMOSD (16–19) and progressive deterioration has been described rarely (4, 13).

Practical Implications

Diagnostic Considerations

MOG-IgG detection should be considered in atypical MS cases to guide therapeutic strategies.

Therapeutic Strategies

The case emphasizes the need for further investigation into the pathogenesis of MOG pathologies to improve treatment approaches.

Disease Understanding

This report contributes to the characterization of MOG-related demyelination and its overlap with MS and NMOSD.

Study Limitations

  • 1
    Single case report limits generalizability.
  • 2
    Retrospective analysis of MOG-IgG may introduce bias.
  • 3
    Lack of CSF MOG-IgG testing due to sensitivity limitations.

Your Feedback

Was this summary helpful?

Back to Immunology